Renalytix(DE:2O9)
€0.060.00 (0.00%)
DE:2O9
Renalytix financials statements
€0.06
At close:0.00 (0.00%)
Renalytix (2O9) Ratios
2 Followers
Renalytix Ratios
DE:2O9's free cash flow for Q2 2026 was $-2.75M. For the 2026 fiscal year, DE:2O9's free cash flow was decreased by $-50.00K and operating cash flow was $-2.70M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Sep 24 | Jun 23 | Sep 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.61 | 1.21 | 0.53 | 1.67 | 3.80 |
| Quick Ratio | 0.52 | 1.17 | 0.53 | 1.62 | 3.70 |
| Cash Ratio | 0.26 | 0.75 | 0.41 | 1.53 | 3.51 |
| Solvency Ratio | -1.28 | -1.56 | -2.09 | -1.91 | -2.23 |
| Operating Cash Flow Ratio | -2.01 | -3.73 | -2.62 | -2.03 | -3.88 |
| Short-Term Operating Cash Flow Coverage | -54.35 | 0.00 | -7.24 | -7.32 | -9.82 |
| Net Current Asset Value | $ -7.64M | $ -7.30M | $ -9.71M | $ 3.22M | $ 24.66M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.24 | 1.36 | 1.07 | 0.29 | 0.20 |
| Debt-to-Equity Ratio | -0.90 | -1.19 | -1.09 | 1.74 | 0.40 |
| Debt-to-Capital Ratio | -9.50 | 6.38 | 12.53 | 0.64 | 0.29 |
| Long-Term Debt-to-Capital Ratio | -2.71 | 6.38 | -1.23 | 0.52 | 0.20 |
| Financial Leverage Ratio | -0.73 | -0.87 | -1.02 | 6.05 | 2.07 |
| Debt Service Coverage Ratio | -16.61 | -39.80 | -6.86 | -9.35 | -11.31 |
| Interest Coverage Ratio | -23.33 | -34.40 | 0.00 | 0.00 | -26591.50 |
| Debt to Market Cap | 0.39 | 0.86 | 0.56 | 0.10 | 0.14 |
| Interest Debt Per Share | 0.02 | 0.09 | 0.08 | 0.15 | 0.18 |
| Net Debt to EBITDA | -0.31 | -0.22 | -0.14 | 0.30 | 0.55 |
| Profitability Margins | |||||
| Gross Profit Margin | 36.67% | 40.00% | 6.82% | 20.60% | 30.91% |
| EBIT Margin | -466.67% | -710.00% | -1261.90% | -1240.70% | -1790.67% |
| EBITDA Margin | -460.00% | -710.00% | -1246.00% | -1225.77% | -1774.21% |
| Operating Profit Margin | -466.67% | -573.33% | -1293.49% | -1244.64% | -1790.67% |
| Pretax Profit Margin | -490.00% | -726.67% | -1461.42% | -1340.14% | -1523.60% |
| Net Profit Margin | -473.33% | -680.00% | -1461.60% | -1340.20% | -1524.44% |
| Continuous Operations Profit Margin | -473.33% | -680.00% | -1461.60% | -1340.20% | -1524.44% |
| Net Income Per EBT | 96.60% | 93.58% | 100.01% | 100.00% | 100.06% |
| EBT Per EBIT | 105.00% | 126.74% | 112.98% | 107.67% | 85.09% |
| Return on Assets (ROA) | -307.87% | -334.43% | -419.67% | -108.29% | -71.57% |
| Return on Equity (ROE) | 224.79% | 291.43% | 425.97% | -654.61% | -147.93% |
| Return on Capital Employed (ROCE) | 1745.31% | -1323.08% | 840.42% | -163.00% | -103.30% |
| Return on Invested Capital (ROIC) | 2247.91% | -1238.11% | -4347.72% | -145.42% | -99.47% |
| Return on Tangible Assets | -307.87% | -334.43% | -419.67% | -154.05% | -91.95% |
| Earnings Yield | -113.99% | -210.67% | -222.26% | -38.85% | -52.10% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.27 | 5.00 | 3.17 | 4.39 | 3.04 |
| Payables Turnover | 0.36 | 0.69 | 0.82 | 0.92 | 0.83 |
| Inventory Turnover | 3.79 | 9.00 | 0.00 | 3.76 | 1.77 |
| Fixed Asset Turnover | 2.49 | 15.00 | 10.60 | 2.79 | 0.96 |
| Asset Turnover | 0.65 | 0.49 | 0.29 | 0.08 | 0.05 |
| Working Capital Turnover Ratio | -5.41 | -1.62 | 0.85 | 0.16 | 0.06 |
| Cash Conversion Cycle | -819.93 | -413.67 | -331.15 | -216.39 | -111.11 |
| Days of Sales Outstanding | 85.40 | 73.00 | 115.13 | 83.23 | 119.95 |
| Days of Inventory Outstanding | 96.31 | 40.56 | 0.00 | 96.99 | 206.34 |
| Days of Payables Outstanding | 1001.63 | 527.22 | 446.28 | 396.61 | 437.40 |
| Operating Cycle | 181.71 | 113.56 | 115.13 | 180.22 | 326.28 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.03 | -0.18 | -0.28 | -0.40 | -0.67 |
| Free Cash Flow Per Share | -0.03 | -0.18 | -0.28 | -0.40 | -0.68 |
| Dividend Paid and CapEx Coverage Ratio | -109.00 | -2845786.96 | -7527.75 | 0.00 | -65.91 |
| Capital Expenditure Coverage Ratio | -109.00 | -2845786.96 | -7527.75 | 0.00 | -65.91 |
| Operating Cash Flow Coverage Ratio | -1.91 | -2.16 | -3.53 | -2.69 | -3.71 |
| Operating Cash Flow to Sales Ratio | -3.63 | -5.97 | -13.15 | -9.60 | -15.40 |
| Free Cash Flow Yield | -88.30% | -184.85% | -200.06% | -27.83% | -53.43% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.88 | -0.47 | -0.45 | -2.57 | -1.92 |
| Price-to-Sales (P/S) Ratio | 4.15 | 3.23 | 6.58 | 34.50 | 29.26 |
| Price-to-Book (P/B) Ratio | -1.97 | -1.38 | -1.92 | 16.85 | 2.84 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.13 | -0.54 | -0.50 | -3.59 | -1.87 |
| Price-to-Operating Cash Flow Ratio | -1.14 | -0.54 | -0.50 | -3.59 | -1.90 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | 0.01 | 0.01 | 0.23 | -0.07 |
| Enterprise Value Multiple | -1.22 | -0.68 | -0.66 | -2.51 | -1.10 |
| Enterprise Value | 16.81M | 14.38M | 18.91M | 104.86M | 57.92M |
| EV to EBITDA | -1.22 | -0.68 | -0.66 | -2.51 | -1.10 |
| EV to Sales | 5.59 | 4.79 | 8.26 | 30.81 | 19.50 |
| EV to Free Cash Flow | -1.52 | -0.80 | -0.63 | -3.21 | -1.25 |
| EV to Operating Cash Flow | -1.54 | -0.80 | -0.63 | -3.21 | -1.27 |
| Tangible Book Value Per Share | -0.02 | -0.07 | -0.07 | 0.07 | 0.43 |
| Shareholders’ Equity Per Share | -0.02 | -0.07 | -0.07 | 0.08 | 0.45 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.03 | 0.06 | -0.00 | -0.00 | -0.00 |
| Revenue Per Share | 0.01 | 0.03 | 0.02 | 0.04 | 0.04 |
| Net Income Per Share | -0.03 | -0.21 | -0.31 | -0.55 | -0.67 |
| Tax Burden | 0.97 | 0.94 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.05 | 1.02 | 1.16 | 1.08 | 0.85 |
| Research & Development to Revenue | 0.00 | 0.30 | 4.10 | 4.20 | 4.93 |
| SG&A to Revenue | 5.03 | 1.77 | 8.63 | 12.65 | 4.36 |
| Stock-Based Compensation to Revenue | 0.00 | 1.07 | 0.75 | 0.86 | 1.56 |
| Income Quality | 0.77 | 0.82 | 0.90 | 0.71 | 0.92 |
Currency in USD
